Dr. Ranveer Nand
Claim this profileAscension Columbia Saint Mary's Hospital - Milwaukee
Studies Breast Cancer
Studies Cancer
8 reported clinical trials
19 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER negative
PR negative
2Cancer
HER2 positive
ER positive
Stage I
Affiliated Hospitals
Clinical Trials Ranveer Nand is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
More about Ranveer Nand
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ranveer Nand has experience with
- Carboplatin
- Crizotinib
- Additional Support Program Via Text Messaging And Telephone-Based Counseling
- Doxorubicin Hydrochloride
- Cyclophosphamide
- Paclitaxel
Breakdown of trials Ranveer Nand has run
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ranveer Nand specialize in?
Ranveer Nand focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER negative.
Is Ranveer Nand currently recruiting for clinical trials?
Yes, Ranveer Nand is currently recruiting for 4 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Ranveer Nand has studied deeply?
Yes, Ranveer Nand has studied treatments such as Carboplatin, Crizotinib, Additional Support Program Via Text Messaging and Telephone-Based Counseling.
What is the best way to schedule an appointment with Ranveer Nand?
Apply for one of the trials that Ranveer Nand is conducting.
What is the office address of Ranveer Nand?
The office of Ranveer Nand is located at: Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee, Wisconsin 53211 United States. This is the address for their practice at the Ascension Columbia Saint Mary's Hospital - Milwaukee.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.